Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.

Stories

Go deeper: The new drugs and therapies keeping us alive longer

Illustration: Rebecca Zisser/Axios 

Americans on average are dying sooner, largely due to the country’s opioid epidemic. But a number of medical advances are helping people who have chronic diseases live longer.

What’s working: Medical researchers and venture capitalists told Axios that these drugs and treatments have immensely helped patients, or could change the face of medicine shortly.

Read more toggle
Show less
Go deeper140 Words
  • Hepatitis C drugs sold by Gilead Sciences and AbbVie essentially eradicate the virus in as few as two months, although side effects vary.
  • Immunotherapy treatments, such as CAR-T, give patients the chance to fight off cancer with modified versions of their own immune cells.
  • New gene therapies are attacking rare disorders, such as one treatment that reverses a rare form of blindness.
  • Gene-modifying systems like CRISPR are giving scientists hope of treating disease at the DNA level.
  • Newer diabetes treatments have been shown to slow the costly and crippling long-term disease.

Be smart: The price tags are huge, and we still don’t know about all of their long-term side effects. There are always tradeoffs in health policy, but a breakthrough drug or treatment may not be all that valuable if people can’t access or afford it.

Go deeper:

Experts divided on trend toward smaller, targeted clinical trials

Deep Dive - Health Care
More stories loading.